New drug CBP-4888 passes first safety check in healthy volunteers
NCT ID NCT05881993
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 36 times
Summary
This study tested a new drug called CBP-4888 in 45 healthy women who were not pregnant. The goal was to see if the drug is safe and how the body processes it. Participants received either a single dose of the drug or a placebo. The study did not aim to treat any disease, only to gather early safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Comanche Biopharma Clinical Research Site #1
San Antonio, Texas, 78217, United States
Conditions
Explore the condition pages connected to this study.